Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/18/2009CN100560128C Repairing paste of emu oil and its production
11/18/2009CN100560127C Effervescent tablet of human interferon-alpha-2b and its preparation process
11/18/2009CN100560059C Co-grinding process for the preparation of a ternary composition
11/17/2009USRE40988 infections caused by HIV-1 or HIV-2; pain; cancers; anorexia nervosa; bulimia; cachexia; obesity; diabetes; asthma; Parkinson's disease; both acute and congestive heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; ulcers
11/17/2009USRE40987 for the treatment and prevention of AIDS
11/17/2009US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619067 Viricidal protein for prevention and treatment of hepatitis infection
11/17/2009US7619066 IL-1ra variants
11/17/2009US7619065 Cystine-knot fold protein
11/17/2009US7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
11/17/2009US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine
11/17/2009US7619000 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
11/17/2009US7618945 inhibiting platelet aggregation; for treatment of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, angiogenesis, cancer, and neurodegenerative disorders
11/17/2009US7618944 Encapsulating in micelle which is a block copolymer containing hydrophilic and hydrophobic blocks
11/17/2009US7618943 Fusion polypeptides, and use thereof in antivascular tumor therapy
11/17/2009US7618942 Controlling insects by contacting with insecticidal Bacillus thuringiensis hybrid protein comprising domains I and II of first native B. thuringiensis delta-endotoxin Cry1A protein, domain III of second native B. thuringiensis delta-endotoxin Cry1F protein, and protoxin segment of native delta endotoxin
11/17/2009US7618941 Treating degenerative joint disorders with tribonectins
11/17/2009US7618939 Isolated azurin or residues from Pseudomonas aeruginosa; inhibiting development of premalignant lesions; expression vectors; kits
11/17/2009US7618938 Ischemia, stroke, infarction; activating hypoxia inducible factor 1 alpha; synergistic neuroprotective effect in primary cortical cells, angiogenesis promotion; increasing expression of Bcl-2 expression, inhibiting caspase 3
11/17/2009US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling
11/17/2009US7618936 Administering to a cancer cell exhibiting reduced WIF-1 expression an effective amount of a polypeptide operably linked to a signal sequence or fused to a heterologous amino acid sequence, wherein said administering inhibits cancer cell proliferation
11/17/2009US7618935 Chaperonin 10 immunosuppression
11/17/2009US7618933 Administering a soluble lymphotoxin-beta receptor, which may be fused to one or more heterologous protein domains, such as a human immunoglobulin Fc domain, optionally incombination with chemotherapy, radiotherapy or bone marrow transplant
11/17/2009US7618818 Method for detecting leptin receptor ligands
11/17/2009US7618787 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelarator and apoptosis inhibitor
11/17/2009US7618786 Method for identifying modulators of human orexin-2 receptor
11/17/2009US7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
11/17/2009US7618653 Biological artificial nerve guide and method of making
11/17/2009US7618648 treating, preventing obesity or being overweight, administering whey protein hydrolyzate, to induce the cellular release of glucagon-like-peptides and cholecystokinins
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618642 Expression cassettes encoding modified human immunodeficiency virus type 1 subtype C envelope glycoproteins
11/17/2009US7618637 Therapeutic mixture comprising chaperone protein for use in treatment and prevention of autoimmune, infectious and allergic disorders
11/17/2009US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009US7618635 Super-antigen fusion proteins and the use thereof
11/17/2009US7618634 Neurotoxic oligomers
11/17/2009US7618632 Expression vector comprising nucleotide sequences coding glucocorticoid-induced tumor necrosis factor receptor protein (GITR) for use in diagnosis, prevention and treatment of cancer, infection, autoimmune, inflammatory and/or transplant rejection
11/17/2009US7618630 Administering to an individual a therapeutically effective amount of an antagonist of an interaction between an alpha 4 subunit-bearing integrin and a ligand for an alpha 4 subunit-bearing integrin
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009US7618614 Intraventricular administration of hepatocyte growth factor (HGF)
11/17/2009US7618394 Needleless syringe using supersonic gas flow for particle delivery
11/17/2009CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/17/2009CA2400117C Novel collagen-like protein clac, a precursor thereof, and genes encoding the same
11/17/2009CA2397244C Ace inhibitor-vasopressin antagonist combinations
11/17/2009CA2341429C Treatment of mucus hypersecretion
11/17/2009CA2318536C Method of and compositions for immunization with the pseudomonas v antigen
11/17/2009CA2291754C Smad-interacting polypeptides and their use
11/17/2009CA2249181C Scf analog compositions and methods
11/17/2009CA2230949C Synthetic peptides that inhibit il-6 activity
11/17/2009CA2211459C A method for making heteromultimeric polypeptides
11/17/2009CA2206515C Identification of genes which allow a microorganism to adapt to a particular environment
11/17/2009CA2116327C Method and compositions for cellular reprogramming
11/16/2009CA2681317A1 A synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide
11/14/2009CA2665958A1 High affinity binding site of hgfr and methods for identification of antagonists thereof
11/12/2009WO2009137837A2 Neuregulin/erbb signaling and integrin
11/12/2009WO2009137829A2 Directed stem cell recruitment
11/12/2009WO2009137821A1 Use of lysophospholipids to treat inflammation
11/12/2009WO2009137796A2 Method of regulating the heat shock response
11/12/2009WO2009137795A2 Methods for treating endoplasmic reticulum (er) stress disorders
11/12/2009WO2009137758A2 Igf-ii/gf-iie binding proteins
11/12/2009WO2009137697A1 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
11/12/2009WO2009137632A2 Hiv immunogen and method of making and using same
11/12/2009WO2009137605A2 AFFINITY MATURED CRIg VARIANTS
11/12/2009WO2009137603A1 Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
11/12/2009WO2009137602A1 Therapeutic modulation of ocular surface lubrication
11/12/2009WO2009137598A2 Methods and composition for modulating hematopoietic stem cell migration
11/12/2009WO2009137572A2 Inhibition of gliadin peptides
11/12/2009WO2009137533A2 Ameliorating nervous systems disorders
11/12/2009WO2009137532A1 Antiviral cell penetrating peptides
11/12/2009WO2009137436A2 Peptide conjugates
11/12/2009WO2009137254A2 Modified factor ix polypeptides and uses thereof
11/12/2009WO2009137217A2 Therapeutic replenishment and enrichment of ocular surface lubrication
11/12/2009WO2009137159A2 Bioactive molecules produced by probiotic bacteria and methods for isolating and using the same
11/12/2009WO2009137112A1 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor
11/12/2009WO2009137103A2 Anti-cancer/anti-viral compounds and methods of use
11/12/2009WO2009137093A1 Method of subcutaneous drug delivery of pthrp analogs
11/12/2009WO2009137091A2 Catestatin (cst) and its variants for treatment of cardiovascular and metabolic disorders
11/12/2009WO2009137080A1 Compositions of gnrh related compounds and processes of preparation
11/12/2009WO2009137078A1 Compositions of peptides and processes of preparation thereof
11/12/2009WO2009136976A2 Il-17ra-il-17rb antagonists and uses thereof
11/12/2009WO2009136805A1 Immunostimulating agent and a method for the production thereof
11/12/2009WO2009136651A1 Topical composition for external use and process for producing the same
11/12/2009WO2009136599A1 Non-covalent crosslinking agent for collagen
11/12/2009WO2009136587A1 Anti-fatigue composition
11/12/2009WO2009136392A2 Methods and compositions for oral administration of exenatide
11/12/2009WO2009136290A1 Functionalized pyrrolidines and use thereof as iap inhibitors
11/12/2009WO2009136173A2 Biomimetic cell scaffolds
11/12/2009WO2009136086A2 Method of screening for antitubercular compounds
11/12/2009WO2009136033A2 Cosmetic use of annexin ii-type proteins for treating dryness of the skin
11/12/2009WO2009136007A1 Peptide homing to brain tumors
11/12/2009WO2009135939A2 Depsipeptide for use in cancer therapy
11/12/2009WO2009135858A1 Sialic acid to support the immune system in the elderly
11/12/2009WO2009135615A2 Means for the treatment and/or prophylaxis of an autoimmune disease and for the formation of regulatory t-cells
11/12/2009WO2009135614A2 Use of a virus regimen for the treatment of diseases
11/12/2009WO2009135603A1 Method of generating hypoallergenic glycoproteins in mutated or transgenic plants or plant cells, and mutated or transgenic plants and plant cells for generating hypoallergenic glycoproteins
11/12/2009WO2009135593A2 Solid pharmaceutical formulation with delayed release
11/12/2009WO2009135494A2 Alpha-lactalbumin composition for the treatment of actinic keratosis
11/12/2009WO2009135306A1 Colostrum-derived fraction for wound healing and skin care
11/12/2009WO2009135258A1 Methods and compositions for the management of pain using omega-conotoxins
1 ... 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 ... 3163